兴齐眼药：关于获得药品注册证书的公告

Core Points - The company, Xingqi Eye Medicine, announced that it has received the drug registration certificate for Oubukain Hydrochloride Eye Drops from the National Medical Products Administration [2] Group 1 - The approval of the drug registration certificate is a significant milestone for the company, indicating regulatory compliance and potential market entry [2] - The product, Oubukain Hydrochloride Eye Drops, is expected to enhance the company's product portfolio and may lead to increased revenue opportunities [2]